Literature DB >> 19057258

Should we recommend surgery to patients with limited small cell carcinoma of the esophagus?

Aminah Jatoi, Robert C Miller.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19057258     DOI: 10.1097/JTO.0b013e31818dd98f

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

1.  Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection.

Authors:  Han-Yu Deng; Peng-Zhi Ni; Yun-Cang Wang; Wen-Ping Wang; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

2.  The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.

Authors:  Han-Yu Deng; Gang Li; Jun Luo; Xin-Rui Li; Guha Alai; Yi-Dan Lin
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

3.  Management of treatment-naïve limited-stage small cell esophagus carcinoma.

Authors:  Haitao Tao; Fangfang Li; Jinliang Wang; Weiwei Dong; Jie Gao; Shunchang Jiao; Yi Hu
Journal:  Saudi Med J       Date:  2015-03       Impact factor: 1.484

4.  Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus.

Authors:  Ji-Feng Feng; Hong-Guang Zhao; Jin-Shi Liu; Qi-Xun Chen
Journal:  Onco Targets Ther       Date:  2013-08-22       Impact factor: 4.147

5.  Multidisciplinary modalities achieve encouraging long-term survival in resectable limited-disease esophageal small cell carcinoma.

Authors:  Xue Hou; Jin-Chang Wei; Jing-Xun Wu; Xin Wang; Jian-Hua Fu; Peng Lin; Hao-Xian Yang
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

6.  Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.

Authors:  Zhenhua Li; Jiali Hu; Pifeng Chen; Zhi Zeng
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.